ALCAM is indirectly modulated by miR-125b in MCF7 cells

dc.contributor.author	Akman, H.B.
dc.contributor.author	Selcuklu, S.D.
dc.contributor.author	Donoghue, M.T.A.
dc.contributor.author	Akhavantabasi, S.
dc.contributor.author	Sapmaz, A.
dc.contributor.author	Spillane, C.
dc.contributor.author	Yakicier, M.C.
dc.contributor.author	Erson-Bensan, A.E.
dc.date.accessioned	2021-12-21T08:41:37Z
dc.date.available	2021-12-21T08:41:37Z
dc.date.issued	2015
dc.identifier.issn	10104283
dc.identifier.uri	https://doi.org/10.1007/s13277-014-2987-5
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1474
dc.description.abstract	MicroRNA (miRNA) deregulation is associated with various cancers. Among an expanding list of cancer-related miRNAs, deregulation of miR-125b has been well documented in many cancers including breast. Based on current knowledge, miR-125b is considered to b
dc.language.iso	English
dc.publisher	Kluwer Academic Publishers
dc.title	ALCAM is indirectly modulated by miR-125b in MCF7 cells
dc.type	Article
dc.relation.journal	Tumor Biology
dc.identifier.issue	5
dc.identifier.startpage	3511
dc.identifier.endpage	3520
dc.identifier.volume	36
dc.identifier.doi	10.1007/s13277-014-2987-5
dc.relation.issue	5
dc.relation.volume	36